Hints and tips:
Related Special Reports
...When the US drugs company Abbott Laboratories acquired a small division of the German chemicals group BASF for $6.9bn 23 years ago, its shares fell on fears that it had overpaid....
...It is seeking additional information from Merck and Abbott Laboratories to try to identify the loopholes and propose legislation to prevent tax avoidance....
...SoftBank founder predicts WeWork V for Victory Masayoshi Son admitted today he had turned a “blind eye” to governance lapses at WeWork but promised a “sharp V-shaped recovery” for the shared offices provider...
...She cleaned the general office space, rather than the laboratories, according to her sworn declaration filed in the case....
...AbbVie, which was spun off from Abbott Laboratories in 2013, saw its shares up more than 6 per cent in Thursday morning trading. Amgen shares were also up 1 per cent....
...One of his touchstones for anti-competitive behaviour is the late 1990s US v Microsoft case, in which the company was found guilty of using its operating system monopoly to stifle competitors like Netscape...
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...“We have historically thought about cancers in an incredibly anatomically based way,” says Gary Gordon, vice-president of oncology at AbbVie....
...Mr Saunders says that, in buying Whole Foods, Amazon is also acquiring a larger laboratory for its experiments in bricks-and-mortar retailing, which have multiplied over the past two years — but only on...
...Mr Read also sought to distance Pfizer from other companies that have been broken up in recent years, such as Abbott Laboratories, which spun out its branded drugs business as AbbVie, and Baxter Health,...
...US pharmaceutical Abbott Laboratories also on Thursday announced a $25bn deal for St Jude Medical, while France’s Sanofi earlier today went public with the details of an unsolicited bid for San Francisco-based...
...AbbVie, a spin-off from Abbott, said it would acquire cancer treatment start-up Stemcentrx for $6bn despite the deal reducing this year’s earnings by 6 per cent....
...Shares in Hikma Pharmaceuticals have taken a dive after it sliced $535m off its offer price for generic medicines business Roxane Laboratories and said it was expecting lower revenues from its acquisition...
...The group forecast revenue of $2bn-$2.1bn for 2016, a significant jump, part of which stems from the added revenues it will receive from Roxane Laboratories, the business it agreed to buy from Boehringer...
...A trio of deals worth a combined $45bn breathed fresh life into the healthcare mergers and acquisitions boom on Thursday as Abbott Laboratories, AbbVie and Sanofi all went shopping for assets....
...Since last Thursday more than $55bn have been spent by large companies, including Abbott Laboratories, AbbVie and Sanofi to secure growth generating assets....
...Shareholders are taking a dim view of the gloomier assessment by Hikma Pharmaceutical of Roxane Laboratories, which it agreed to buy last year....
...Abbott Laboratories, AbbVie and Sanofi spent a combined $45bn last week as analysts said that the fundamentals for healthcare deals remained intact: companies need to do deals to boost growth and bolster...
...As head of the firm’s M&A practice, Mr Cooke recently led the team advising Hikma Pharmaceuticals on its $2.65bn acquisition of Roxane from Boehringer Ingelheim, and Shire on its proposed merger with AbbVie...
...J&J has dismissed suggestions it should split up the business as Abbott did when it hived off its pharmaceuticals company as AbbVie in 2014....
...division off into a new company, AbbVie, in 2014....
...So could Mr Saunders be about to put on his laboratory coat and buy a company such as Biogen or AbbVie? “It’s possible....
...Shire’s pursuit of Baxalta marks a reversal of last year’s initially hostile bid for the UK-listed company by AbbVie, another Illinois-based drugmaker recently spun-off from Abbott Laboratories....
International Edition